| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ubiquitin-like ligase-substrate adaptor activity | PRAMEF7 PRAMEF9 PRAMEF15 PRAMEF12 PRAMEF4 PRAMEF8 PRAMEF27 PRAMEF11 | 2.21e-08 | 82 | 114 | 8 | GO:1990756 |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 2.66e-08 | 55 | 114 | 7 | GO:0042974 | |
| GeneOntologyMolecularFunction | enzyme-substrate adaptor activity | PRAMEF7 PRAMEF9 PRAMEF15 PRAMEF12 PRAMEF4 PRAMEF8 PRAMEF27 PRAMEF11 | 7.08e-08 | 95 | 114 | 8 | GO:0140767 |
| GeneOntologyMolecularFunction | nuclear receptor binding | PRAMEF7 PRAMEF15 PRAMEF12 PRAMEF4 PRAMEF8 AR PRAMEF27 PRAMEF11 | 1.20e-05 | 187 | 114 | 8 | GO:0016922 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 1.78e-04 | 144 | 114 | 6 | GO:0016798 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH group of donors | 6.58e-04 | 30 | 114 | 3 | GO:0016645 | |
| GeneOntologyBiologicalProcess | blastocyst development | PRAMEF7 PRAMEF15 ZFP14 PRAMEF12 PRAMEF4 PRAMEF8 SPECC1 NLRP9 TM4SF1 PRAMEF11 | 5.41e-08 | 179 | 113 | 10 | GO:0001824 |
| GeneOntologyBiologicalProcess | blastocyst formation | 2.35e-07 | 78 | 113 | 7 | GO:0001825 | |
| GeneOntologyBiologicalProcess | oocyte development | 1.21e-06 | 99 | 113 | 7 | GO:0048599 | |
| GeneOntologyBiologicalProcess | oocyte differentiation | 1.58e-06 | 103 | 113 | 7 | GO:0009994 | |
| GeneOntologyBiologicalProcess | oogenesis | 2.44e-05 | 156 | 113 | 7 | GO:0048477 | |
| GeneOntologyBiologicalProcess | somatic stem cell population maintenance | 2.87e-05 | 108 | 113 | 6 | GO:0035019 | |
| GeneOntologyBiologicalProcess | female gamete generation | PRAMEF7 PRAMEF15 PRAMEF12 WNT4 PRAMEF4 PRAMEF8 MMP2 PRAMEF11 | 3.18e-05 | 223 | 113 | 8 | GO:0007292 |
| GeneOntologyBiologicalProcess | response to nickel cation | 8.89e-05 | 3 | 113 | 2 | GO:0010045 | |
| GeneOntologyBiologicalProcess | tertiary branching involved in mammary gland duct morphogenesis | 8.89e-05 | 3 | 113 | 2 | GO:0060748 | |
| GeneOntologyCellularComponent | Cul2-RING ubiquitin ligase complex | PRAMEF7 PRAMEF9 PRAMEF15 PRAMEF12 PRAMEF4 PRAMEF8 PRAMEF27 PRAMEF11 | 1.61e-10 | 47 | 114 | 8 | GO:0031462 |
| GeneOntologyCellularComponent | acrosomal vesicle | PRAMEF7 PRAMEF15 LYZL6 PRAMEF12 PRAMEF4 PRAMEF8 IL4I1 SPACA3 PRAMEF11 | 1.95e-06 | 206 | 114 | 9 | GO:0001669 |
| GeneOntologyCellularComponent | cullin-RING ubiquitin ligase complex | PRAMEF7 PRAMEF9 PRAMEF15 PRAMEF12 PRAMEF4 PRAMEF8 PRAMEF27 PRAMEF11 | 2.15e-05 | 212 | 114 | 8 | GO:0031461 |
| GeneOntologyCellularComponent | motile cilium | PRAMEF7 IFT172 PRAMEF15 LYZL6 PRAMEF12 PRAMEF4 PRAMEF8 IL4I1 SPACA3 PRAMEF11 | 2.50e-05 | 355 | 114 | 10 | GO:0031514 |
| GeneOntologyCellularComponent | secretory granule | PRAMEF7 GHDC PRAMEF15 LYZL6 TMPRSS4 PRAMEF12 PRAMEF4 PRAMEF8 OLR1 SLC6A9 PIGR SURF4 IL4I1 SPACA3 PRAMEF11 KPNB1 | 1.23e-04 | 1014 | 114 | 16 | GO:0030141 |
| GeneOntologyCellularComponent | ubiquitin ligase complex | PRAMEF7 PRAMEF9 RNF31 PRAMEF15 PRAMEF12 PRAMEF4 PRAMEF8 PRAMEF27 PRAMEF11 | 1.35e-04 | 352 | 114 | 9 | GO:0000151 |
| GeneOntologyCellularComponent | cilium | PRAMEF7 IFT172 PRAMEF15 LYZL6 TSPEAR PRAMEF12 PRAMEF4 ADGRV1 PRAMEF8 USH1G VCAN IL4I1 SPACA3 PRAMEF11 | 3.81e-04 | 898 | 114 | 14 | GO:0005929 |
| GeneOntologyCellularComponent | apical part of cell | SLC44A4 LCT SPECC1 CLDN1 SLC6A6 SLC6A9 KCNB1 PLEC OTOG PDZD2 DUOXA2 | 3.95e-04 | 592 | 114 | 11 | GO:0045177 |
| GeneOntologyCellularComponent | filamentous actin | 1.16e-03 | 38 | 114 | 3 | GO:0031941 | |
| GeneOntologyCellularComponent | secretory vesicle | PRAMEF7 GHDC PRAMEF15 LYZL6 TMPRSS4 PRAMEF12 PRAMEF4 PRAMEF8 OLR1 SLC6A9 PIGR SURF4 IL4I1 SPACA3 PRAMEF11 KPNB1 | 1.19e-03 | 1246 | 114 | 16 | GO:0099503 |
| GeneOntologyCellularComponent | lateral plasma membrane | 1.49e-03 | 90 | 114 | 4 | GO:0016328 | |
| GeneOntologyCellularComponent | perisynaptic extracellular matrix | 1.57e-03 | 11 | 114 | 2 | GO:0098966 | |
| GeneOntologyCellularComponent | parallel fiber to Purkinje cell synapse | 1.66e-03 | 43 | 114 | 3 | GO:0098688 | |
| GeneOntologyCellularComponent | synapse-associated extracellular matrix | 2.21e-03 | 13 | 114 | 2 | GO:0099535 | |
| MousePheno | abnormal jejunum morphology | 6.81e-09 | 41 | 90 | 7 | MP:0004002 | |
| MousePheno | abnormal spermatogonia proliferation | 1.85e-08 | 47 | 90 | 7 | MP:0002685 | |
| MousePheno | abnormal duodenum morphology | 1.67e-07 | 64 | 90 | 7 | MP:0003271 | |
| MousePheno | abnormal circulating amylase level | PRAMEF7 BACH2 PRAMEF15 PRAMEF12 PRAMEF4 PRAMEF8 PRAMEF11 DUOXA2 | 7.18e-06 | 156 | 90 | 8 | MP:0008804 |
| MousePheno | increased circulating amylase level | 1.13e-05 | 119 | 90 | 7 | MP:0008806 | |
| MousePheno | increased male germ cell apoptosis | PRAMEF7 PRAMEF15 PRAMEF12 PRAMEF4 PRAMEF8 AR PRAMEF27 PRAMEF11 | 2.90e-05 | 189 | 90 | 8 | MP:0014052 |
| MousePheno | abnormal urinary bladder morphology | PRAMEF7 IPO7 PRAMEF15 PRAMEF12 PRAMEF4 PRAMEF8 AR DHCR7 PRAMEF11 | 2.95e-05 | 247 | 90 | 9 | MP:0000538 |
| MousePheno | abnormal cecum morphology | 4.17e-05 | 99 | 90 | 6 | MP:0000494 | |
| MousePheno | abnormal vitreous body morphology | PRAMEF7 PRAMEF15 PRAMEF12 PRAMEF4 PRAMEF8 STK35 SYNJ1 VCAN MMP2 PRAMEF27 PRAMEF11 | 9.40e-05 | 429 | 90 | 11 | MP:0002699 |
| MousePheno | enlarged urinary bladder | 1.01e-04 | 116 | 90 | 6 | MP:0011874 | |
| MousePheno | abnormal male germ cell apoptosis | PRAMEF7 PRAMEF15 PRAMEF12 PRAMEF4 PRAMEF8 AR PRAMEF27 PRAMEF11 | 1.38e-04 | 236 | 90 | 8 | MP:0008280 |
| MousePheno | azoospermia | PRAMEF7 PRAMEF15 PRAMEF12 PRAMEF4 PRAMEF8 AR PRAMEF27 PRAMEF11 | 1.74e-04 | 244 | 90 | 8 | MP:0005159 |
| MousePheno | abnormal male germ cell physiology | PRAMEF7 PRAMEF15 PRAMEF12 PRAMEF4 PRAMEF8 AR PRAMEF27 PRAMEF11 | 1.74e-04 | 244 | 90 | 8 | MP:0020362 |
| MousePheno | abnormal small intestine morphology | 2.01e-04 | 187 | 90 | 7 | MP:0000496 | |
| MousePheno | abnormal testis weight | PRAMEF7 PRAMEF15 LGR4 PRAMEF12 PRAMEF4 PRAMEF8 STK35 AR PRAMEF27 PRAMEF11 | 2.04e-04 | 391 | 90 | 10 | MP:0004850 |
| MousePheno | absent gametes | PRAMEF7 PRAMEF15 PRAMEF12 PRAMEF4 PRAMEF8 AR PRAMEF27 PRAMEF11 | 2.41e-04 | 256 | 90 | 8 | MP:0001117 |
| MousePheno | increased circulating alanine transaminase level | PRAMEF7 PRAMEF15 PRAMEF12 PRAMEF4 PRAMEF8 STK35 PHKB ELAVL1 PRAMEF11 FHIP2B | 3.10e-04 | 412 | 90 | 10 | MP:0002941 |
| MousePheno | abnormal germ cell physiology | PRAMEF7 PRAMEF15 PRAMEF12 PRAMEF4 PRAMEF8 AR PRAMEF27 PRAMEF11 | 3.20e-04 | 267 | 90 | 8 | MP:0020363 |
| MousePheno | increased kidney weight | 3.42e-04 | 145 | 90 | 6 | MP:0003917 | |
| MousePheno | abnormal kidney weight | 3.84e-04 | 208 | 90 | 7 | MP:0002707 | |
| MousePheno | small kidney | PRAMEF7 PRAMEF15 LGR4 PRAMEF12 WNT4 PRAMEF4 PRAMEF8 DHCR7 MMP2 PRAMEF11 | 3.96e-04 | 425 | 90 | 10 | MP:0002989 |
| MousePheno | enlarged lymph nodes | PRAMEF7 IPO7 PRAMEF15 ZFP14 PRAMEF12 PRAMEF4 PRAMEF8 SLC6A6 CACNA1G MMP2 PRAMEF11 | 4.00e-04 | 507 | 90 | 11 | MP:0000702 |
| MousePheno | small metanephros | 4.05e-04 | 5 | 90 | 2 | MP:0011365 | |
| MousePheno | abnormal lens morphology | PRAMEF7 PRAMEF15 LGR4 PRAMEF12 PRAMEF4 PRAMEF8 STK35 PHKB TRPM3 LTBP2 MMP2 PRAMEF27 PRAMEF11 | 5.11e-04 | 699 | 90 | 13 | MP:0001303 |
| Domain | PRAME_family | 1.09e-09 | 19 | 113 | 6 | IPR026271 | |
| Domain | EGF_3 | 9.17e-05 | 235 | 113 | 8 | PS50026 | |
| Domain | PET | 5.36e-04 | 6 | 113 | 2 | PF06297 | |
| Domain | EPTP | 5.36e-04 | 6 | 113 | 2 | PF03736 | |
| Domain | PET_domain | 5.36e-04 | 6 | 113 | 2 | IPR010442 | |
| Domain | EPTP | 5.36e-04 | 6 | 113 | 2 | IPR005492 | |
| Domain | PET | 5.36e-04 | 6 | 113 | 2 | PS51303 | |
| Domain | EAR | 7.47e-04 | 7 | 113 | 2 | IPR009039 | |
| Domain | EAR | 7.47e-04 | 7 | 113 | 2 | PS50912 | |
| Domain | Glyco_hydro_22_lys | 7.47e-04 | 7 | 113 | 2 | IPR000974 | |
| Domain | Glyco_hydro_22_CS | 7.47e-04 | 7 | 113 | 2 | IPR019799 | |
| Domain | - | PRAMEF7 PRAMEF15 LGR4 PRAMEF12 PRAMEF4 PRAMEF8 NLRP9 PRAMEF27 | 7.48e-04 | 321 | 113 | 8 | 3.80.10.10 |
| Domain | EGF-like_dom | 8.01e-04 | 249 | 113 | 7 | IPR000742 | |
| Domain | L_dom-like | PRAMEF7 PRAMEF15 LGR4 PRAMEF12 PRAMEF4 PRAMEF8 NLRP9 PRAMEF27 | 8.61e-04 | 328 | 113 | 8 | IPR032675 |
| Domain | EGF_1 | 9.21e-04 | 255 | 113 | 7 | PS00022 | |
| Domain | Glyco_hydro_22 | 9.92e-04 | 8 | 113 | 2 | IPR001916 | |
| Domain | LACTALBUMIN_LYSOZYME_2 | 9.92e-04 | 8 | 113 | 2 | PS51348 | |
| Domain | Lys | 9.92e-04 | 8 | 113 | 2 | PF00062 | |
| Domain | LACTALBUMIN_LYSOZYME_1 | 9.92e-04 | 8 | 113 | 2 | PS00128 | |
| Domain | LYZ1 | 9.92e-04 | 8 | 113 | 2 | SM00263 | |
| Domain | EGF | 1.01e-03 | 126 | 113 | 5 | PF00008 | |
| Domain | EGF_2 | 1.15e-03 | 265 | 113 | 7 | PS01186 | |
| Domain | Lysozyme-like_dom | 1.58e-03 | 10 | 113 | 2 | IPR023346 | |
| Domain | SAM | 2.00e-03 | 88 | 113 | 4 | SM00454 | |
| Domain | SAM_2 | 2.23e-03 | 43 | 113 | 3 | PF07647 | |
| Domain | TIL | 2.30e-03 | 12 | 113 | 2 | PF01826 | |
| Domain | C8 | 2.30e-03 | 12 | 113 | 2 | PF08742 | |
| Domain | LamG | 2.38e-03 | 44 | 113 | 3 | SM00282 | |
| Domain | SAM_DOMAIN | 2.65e-03 | 95 | 113 | 4 | PS50105 | |
| Domain | - | 2.65e-03 | 95 | 113 | 4 | 2.60.120.200 | |
| Domain | Unchr_dom_Cys-rich | 2.71e-03 | 13 | 113 | 2 | IPR014853 | |
| Domain | C8 | 2.71e-03 | 13 | 113 | 2 | SM00832 | |
| Domain | - | 2.71e-03 | 13 | 113 | 2 | 2.10.10.10 | |
| Domain | SAM | 2.86e-03 | 97 | 113 | 4 | IPR001660 | |
| Domain | EGF | 3.07e-03 | 235 | 113 | 6 | SM00181 | |
| Domain | FN_type2_col-bd | 3.15e-03 | 14 | 113 | 2 | IPR000562 | |
| Domain | FN2_2 | 3.15e-03 | 14 | 113 | 2 | PS51092 | |
| Domain | IMPORTIN_B_NT | 3.15e-03 | 14 | 113 | 2 | PS50166 | |
| Domain | TIL_dom | 3.15e-03 | 14 | 113 | 2 | IPR002919 | |
| Domain | fn2 | 3.15e-03 | 14 | 113 | 2 | PF00040 | |
| Domain | FN2_1 | 3.15e-03 | 14 | 113 | 2 | PS00023 | |
| Domain | FN2 | 3.15e-03 | 14 | 113 | 2 | SM00059 | |
| Domain | IBN_N | 3.62e-03 | 15 | 113 | 2 | PF03810 | |
| Domain | - | 3.93e-03 | 106 | 113 | 4 | 1.10.150.50 | |
| Domain | VWD | 4.12e-03 | 16 | 113 | 2 | SM00216 | |
| Domain | VWF_type-D | 4.12e-03 | 16 | 113 | 2 | IPR001846 | |
| Domain | IBN_N | 4.12e-03 | 16 | 113 | 2 | SM00913 | |
| Domain | VWFD | 4.12e-03 | 16 | 113 | 2 | PS51233 | |
| Domain | VWD | 4.12e-03 | 16 | 113 | 2 | PF00094 | |
| Domain | Importin-beta_N | 4.65e-03 | 17 | 113 | 2 | IPR001494 | |
| Domain | EGF-like_CS | 5.12e-03 | 261 | 113 | 6 | IPR013032 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 5.21e-03 | 18 | 113 | 2 | PS00754 | |
| Domain | Laminin_G | 5.23e-03 | 58 | 113 | 3 | IPR001791 | |
| Domain | SAM/pointed | 5.58e-03 | 117 | 113 | 4 | IPR013761 | |
| Domain | VWC_out | 5.80e-03 | 19 | 113 | 2 | SM00215 | |
| Domain | SNF | 5.80e-03 | 19 | 113 | 2 | PF00209 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 5.80e-03 | 19 | 113 | 2 | PS00610 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 5.80e-03 | 19 | 113 | 2 | PS50267 | |
| Domain | Na/ntran_symport | 5.80e-03 | 19 | 113 | 2 | IPR000175 | |
| Pathway | PID_BETA_CATENIN_NUC_PATHWAY | 6.56e-05 | 80 | 75 | 5 | M223 | |
| Pubmed | PRAMEF7 PRAMEF15 PRAMEF12 PRAMEF4 PRAMEF8 NLRP9 PRAMEF27 PRAMEF11 | 3.28e-14 | 28 | 115 | 8 | 25089626 | |
| Pubmed | 2.69e-13 | 20 | 115 | 7 | 26694250 | ||
| Pubmed | 5.88e-13 | 22 | 115 | 7 | 31729367 | ||
| Pubmed | 1.64e-12 | 25 | 115 | 7 | 37451217 | ||
| Pubmed | Differential expression of PRAMEL1, a cancer/testis antigen, during spermatogenesis in the mouse. | 1.38e-11 | 17 | 115 | 6 | 23565261 | |
| Pubmed | 1.38e-11 | 17 | 115 | 6 | 37781892 | ||
| Pubmed | 2.06e-11 | 18 | 115 | 6 | 23894331 | ||
| Pubmed | Pramel15 facilitates zygotic nuclear DNMT1 degradation and DNA demethylation. | 2.06e-11 | 18 | 115 | 6 | 39181896 | |
| Pubmed | Oogenesin is a novel mouse protein expressed in oocytes and early cleavage-stage embryos. | 2.06e-11 | 18 | 115 | 6 | 12890732 | |
| Pubmed | Oocyte-specific gene Oog1 suppresses the expression of spermatogenesis-specific genes in oocytes. | 2.06e-11 | 18 | 115 | 6 | 29731491 | |
| Pubmed | 2.06e-11 | 18 | 115 | 6 | 14675769 | ||
| Pubmed | 2.24e-11 | 35 | 115 | 7 | 19389355 | ||
| Pubmed | Pramel7 mediates ground-state pluripotency through proteasomal-epigenetic combined pathways. | 3.00e-11 | 19 | 115 | 6 | 28604677 | |
| Pubmed | 4.27e-11 | 20 | 115 | 6 | 16580637 | ||
| Pubmed | Pramel7 mediates LIF/STAT3-dependent self-renewal in embryonic stem cells. | 4.27e-11 | 20 | 115 | 6 | 21425410 | |
| Pubmed | 1.10e-10 | 23 | 115 | 6 | 19480014 | ||
| Pubmed | Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei. | 1.93e-10 | 25 | 115 | 6 | 12620990 | |
| Pubmed | Expression profiling in transgenic FVB/N embryonic stem cells overexpressing STAT3. | 2.50e-10 | 26 | 115 | 6 | 18500982 | |
| Pubmed | Thirteen Ovary-Enriched Genes Are Individually Not Essential for Female Fertility in Mice. | 6.38e-10 | 30 | 115 | 6 | 38786026 | |
| Pubmed | LSM14B is essential for oocyte meiotic maturation by regulating maternal mRNA storage and clearance. | 9.68e-10 | 32 | 115 | 6 | 37889087 | |
| Pubmed | 9.63e-09 | 46 | 115 | 6 | 17287250 | ||
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | 1.62e-08 | 50 | 115 | 6 | 31806660 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | PRAMEF7 TNC PRAMEF15 LGR4 PRAMEF12 PRAMEF4 PRAMEF8 CACNA1G PLEC OBI1 PRAMEF11 | 3.72e-08 | 363 | 115 | 11 | 14691545 |
| Pubmed | 4.03e-08 | 58 | 115 | 6 | 31598710 | ||
| Pubmed | 4.47e-08 | 59 | 115 | 6 | 11279525 | ||
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | PRAMEF7 IPO7 PRAMEF15 PRAMEF12 PRAMEF4 PRAMEF8 AIFM1 VCAN PLEC PRAMEF11 KPNB1 | 2.88e-06 | 564 | 115 | 11 | 21565611 |
| Pubmed | PRAMEF7 PRAMEF15 LGR4 PRAMEF12 PRAMEF4 PRAMEF8 PHKB SYNJ1 TSR1 VCAN PEAK1 PLEC PRAMEF11 FHIP2B PARP12 | 3.02e-06 | 1084 | 115 | 15 | 11544199 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 16493581 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 12475939 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 17728259 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 26122225 | ||
| Pubmed | Role of fibrillar Tenascin-C in metastatic pancreatic cancer. | 1.08e-05 | 2 | 115 | 2 | 19287959 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 25724186 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 37490546 | ||
| Pubmed | Androgen induces a switch from cytoplasmic retention to nuclear import of the androgen receptor. | 1.08e-05 | 2 | 115 | 2 | 24100013 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 11948127 | ||
| Pubmed | Deficiency of the cytoskeletal protein SPECC1L leads to oblique facial clefting. | 1.08e-05 | 2 | 115 | 2 | 21703590 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 27415424 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 15073129 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 32014455 | ||
| Pubmed | TMPRSS4 promotes cancer stem cell traits by regulating CLDN1 in hepatocellular carcinoma. | 1.08e-05 | 2 | 115 | 2 | 28651932 | |
| Pubmed | PRAMEF7 PRAMEF15 PRAMEF12 PRAMEF4 PRAMEF8 NLRP9 SURF4 PRAMEF11 | 1.36e-05 | 326 | 115 | 8 | 17015433 | |
| Pubmed | Tenascin-cmediated vasculogenic mimicry formation via regulation of MMP2/MMP9 in glioma. | 3.24e-05 | 3 | 115 | 2 | 31754182 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 32718331 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 32754286 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 31661551 | ||
| Pubmed | Lgr4 promotes prostate tumorigenesis through the Jmjd2a/AR signaling pathway. | 3.24e-05 | 3 | 115 | 2 | 27743893 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 27488116 | ||
| Pubmed | Peak in matrix metaloproteinases-2 levels observed during recovery from olfactory nerve injury. | 3.24e-05 | 3 | 115 | 2 | 18303576 | |
| Pubmed | 3.85e-05 | 20 | 115 | 3 | 21750040 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 5.93e-05 | 202 | 115 | 6 | 33005030 | |
| Pubmed | TM4SF1 Promotes Metastasis of Pancreatic Cancer via Regulating the Expression of DDR1. | 6.48e-05 | 4 | 115 | 2 | 28368050 | |
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 11382769 | ||
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 16704975 | ||
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 16014814 | ||
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 12011088 | ||
| Pubmed | Transportins 1 and 2 are redundant nuclear import factors for hnRNP A1 and HuR. | 6.48e-05 | 4 | 115 | 2 | 15037768 | |
| Pubmed | Proteolytic cleavage of versican during limb joint development. | 6.48e-05 | 4 | 115 | 2 | 20101710 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 6.97e-05 | 208 | 115 | 6 | 33230847 | |
| Pubmed | Deterministic and stochastic allele specific gene expression in single mouse blastomeres. | PRAMEF7 PRAMEF15 PRAMEF12 WNT4 PRAMEF4 PRAMEF8 AIFM1 PRAMEF11 | 8.67e-05 | 424 | 115 | 8 | 21731673 |
| Pubmed | 9.72e-05 | 27 | 115 | 3 | 23824573 | ||
| Pubmed | MGAT4B LAYN LYZL6 GPR78 TMPRSS4 ADAM30 WNT4 SLC44A4 CLDN1 MFSD13A IL4I1 SPACA3 | 1.06e-04 | 985 | 115 | 12 | 12975309 | |
| Pubmed | 1.08e-04 | 5 | 115 | 2 | 10209022 | ||
| Pubmed | Acetylation modulates thyroid hormone receptor intracellular localization and intranuclear mobility. | 1.08e-04 | 5 | 115 | 2 | 31319097 | |
| Pubmed | Recognition Elements in the Histone H3 and H4 Tails for Seven Different Importins. | 1.08e-04 | 5 | 115 | 2 | 27528606 | |
| Pubmed | The importin beta/importin 7 heterodimer is a functional nuclear import receptor for histone H1. | 1.08e-04 | 5 | 115 | 2 | 10228156 | |
| Pubmed | 1.08e-04 | 5 | 115 | 2 | 10409496 | ||
| Pubmed | 1.08e-04 | 5 | 115 | 2 | 17906286 | ||
| Pubmed | 1.08e-04 | 5 | 115 | 2 | 15342649 | ||
| Pubmed | Multiple pathways contribute to nuclear import of core histones. | 1.08e-04 | 5 | 115 | 2 | 11493596 | |
| Pubmed | 1.08e-04 | 5 | 115 | 2 | 9214382 | ||
| Pubmed | 1.08e-04 | 5 | 115 | 2 | 24334608 | ||
| Pubmed | Expression of NG2 proteoglycan during endochondral and intramembranous ossification. | 1.08e-04 | 5 | 115 | 2 | 12950088 | |
| Pubmed | The G protein-coupled receptor repertoires of human and mouse. | 1.41e-04 | 79 | 115 | 4 | 12679517 | |
| Pubmed | 1.61e-04 | 6 | 115 | 2 | 24785493 | ||
| Pubmed | Inhibition of nuclear import by the proapoptotic protein CC3. | 1.61e-04 | 6 | 115 | 2 | 15282309 | |
| Pubmed | Proteolytic cleavage of versican during cardiac cushion morphogenesis. | 1.61e-04 | 6 | 115 | 2 | 16691565 | |
| Pubmed | A common protein interaction domain links two recently identified epilepsy genes. | 1.61e-04 | 6 | 115 | 2 | 12095917 | |
| Pubmed | The novel EPTP repeat defines a superfamily of proteins implicated in epileptic disorders. | 1.61e-04 | 6 | 115 | 2 | 12217514 | |
| Pubmed | 1.61e-04 | 347 | 115 | 7 | 16033648 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 1.95e-04 | 86 | 115 | 4 | 28327460 | |
| Pubmed | Gene expression in the mouse eye: an online resource for genetics using 103 strains of mice. | 2.25e-04 | 7 | 115 | 2 | 19727342 | |
| Pubmed | 2.25e-04 | 7 | 115 | 2 | 20058854 | ||
| Pubmed | 2.25e-04 | 7 | 115 | 2 | 15964792 | ||
| Pubmed | Identification of binding partners interacting with the α1-N-propeptide of type V collagen. | 2.25e-04 | 7 | 115 | 2 | 20979576 | |
| Pubmed | 2.25e-04 | 7 | 115 | 2 | 37174615 | ||
| Pubmed | 2.25e-04 | 7 | 115 | 2 | 10891500 | ||
| Pubmed | 2.25e-04 | 7 | 115 | 2 | 23354118 | ||
| Pubmed | 2.79e-04 | 638 | 115 | 9 | 31182584 | ||
| Pubmed | Microarray-based mutation analysis of 183 Spanish families with Usher syndrome. | 3.00e-04 | 8 | 115 | 2 | 19683999 | |
| Pubmed | 3.00e-04 | 8 | 115 | 2 | 12619136 | ||
| Pubmed | 3.00e-04 | 8 | 115 | 2 | 9687515 | ||
| Pubmed | Transportin 1 is a major nuclear import receptor of the nitric oxide synthase interacting protein. | 3.00e-04 | 8 | 115 | 2 | 36690276 | |
| Pubmed | Maternal microRNAs are essential for mouse zygotic development. | 3.05e-04 | 273 | 115 | 6 | 17369397 | |
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 3.10e-04 | 97 | 115 | 4 | 27559042 | |
| Pubmed | 3.62e-04 | 101 | 115 | 4 | 10997877 | ||
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 3.62e-04 | 101 | 115 | 4 | 20551380 | |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 3.62e-04 | 101 | 115 | 4 | 23382219 | |
| Pubmed | 3.84e-04 | 9 | 115 | 2 | 22688677 | ||
| Pubmed | 3.84e-04 | 9 | 115 | 2 | 30282023 | ||
| Cytoband | 1p36.21 | 2.53e-10 | 63 | 115 | 7 | 1p36.21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p36 | PRAMEF7 PRAMEF9 PRAMEF15 PRAMEF12 WNT4 PRAMEF4 PRAMEF8 PLEKHG5 PRAMEF27 PRAMEF11 | 8.90e-06 | 681 | 115 | 10 | chr1p36 |
| Cytoband | 17q11.2 | 2.72e-03 | 110 | 115 | 3 | 17q11.2 | |
| GeneFamily | PRAME family | PRAMEF7 PRAMEF9 PRAMEF15 PRAMEF12 PRAMEF4 PRAMEF8 PRAMEF27 PRAMEF11 | 1.07e-13 | 24 | 84 | 8 | 686 |
| GeneFamily | Prickle planar cell polarity proteins|LIM domain containing | 1.27e-04 | 4 | 84 | 2 | 1184 | |
| GeneFamily | G protein-coupled receptors, Class C orphans | 4.41e-04 | 7 | 84 | 2 | 285 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 4.76e-04 | 78 | 84 | 4 | 262 | |
| GeneFamily | Sterile alpha motif domain containing | 7.51e-04 | 88 | 84 | 4 | 760 | |
| GeneFamily | Lysozymes, c-type | 7.52e-04 | 9 | 84 | 2 | 1174 | |
| GeneFamily | Armadillo repeat containing|Importins | 3.11e-03 | 18 | 84 | 2 | 596 | |
| GeneFamily | Claudins | 5.06e-03 | 23 | 84 | 2 | 488 | |
| GeneFamily | Fibronectin type III domain containing | 6.59e-03 | 160 | 84 | 4 | 555 | |
| GeneFamily | WD repeat domain containing | 7.50e-03 | 262 | 84 | 5 | 362 | |
| Coexpression | KOHOUTEK_CCNT2_TARGETS | PRAMEF7 PRAMEF15 PRAMEF12 PRAMEF4 PRAMEF8 MMP2 PRAMEF27 PRAMEF11 | 2.14e-09 | 81 | 112 | 8 | MM938 |
| Coexpression | KINNEY_DNMT1_METHYLATION_TARGETS | 6.49e-09 | 34 | 112 | 6 | MM955 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED | 1.62e-07 | 57 | 112 | 6 | MM1262 | |
| Coexpression | MORI_SMALL_PRE_BII_LYMPHOCYTE_UP | 2.16e-07 | 98 | 112 | 7 | MM592 | |
| Coexpression | HUANG_GATA2_TARGETS_DN | 2.16e-07 | 98 | 112 | 7 | MM942 | |
| Coexpression | INGRAM_SHH_TARGETS_UP | PRAMEF7 PRAMEF15 PRAMEF12 PRAMEF4 PRAMEF8 SLC6A6 PRAMEF27 PRAMEF11 | 3.70e-07 | 156 | 112 | 8 | MM550 |
| Coexpression | DESCARTES_ORGANOGENESIS_SCHWANN_CELL_PRECURSOR | 4.07e-06 | 98 | 112 | 6 | MM3656 | |
| Coexpression | FOSTER_KDM1A_TARGETS_UP | PRAMEF7 PRICKLE1 PRAMEF15 PRAMEF12 PRAMEF4 PRAMEF8 MMP2 PRAMEF11 OTOG | 9.12e-06 | 317 | 112 | 9 | MM956 |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS | 1.27e-05 | 180 | 112 | 7 | MM612 | |
| Coexpression | YAGUE_PRETUMOR_DRUG_RESISTANCE_DN | 2.11e-05 | 13 | 112 | 3 | M2070 | |
| Coexpression | NABA_CORE_MATRISOME | 2.16e-05 | 270 | 112 | 8 | MM17057 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | PRAMEF7 IPO7 PRICKLE1 NBEAL1 PRAMEF15 NOXRED1 PRAMEF12 PRAMEF4 PRAMEF8 SPECC1 USP20 SLC6A6 ELAVL1 PCNX1 PLEC PRAMEF11 | 2.33e-05 | 1124 | 112 | 16 | MM1070 |
| Coexpression | NABA_CORE_MATRISOME | 2.46e-05 | 275 | 112 | 8 | M5884 | |
| Coexpression | MIKKELSEN_ES_ICP_WITH_H3K4ME3 | PRAMEF7 GHDC PRAMEF15 COL5A3 PRAMEF12 PRAMEF4 PRAMEF8 SLC44A4 PLEKHG5 WDR83OS ADPRHL1 PRAMEF27 PRAMEF11 | 4.17e-05 | 807 | 112 | 13 | MM855 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_3_CELL | 5.43e-05 | 226 | 112 | 7 | M45709 | |
| Coexpression | YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN | PRAMEF7 PRAMEF15 PRAMEF12 PRAMEF4 PRAMEF8 KRT39 FAM131B PRAMEF11 | 5.61e-05 | 309 | 112 | 8 | MM1244 |
| Coexpression | RODWELL_AGING_KIDNEY_UP | PRICKLE1 TNC TMPRSS4 RNF213 CLDN1 SLC6A6 PIGR VCAN IL4I1 PARP12 | 5.91e-05 | 501 | 112 | 10 | M5389 |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_DN | 6.40e-05 | 232 | 112 | 7 | MM1019 | |
| Coexpression | FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON | 8.10e-05 | 166 | 112 | 6 | M39026 | |
| Coexpression | BROWN_MYELOID_CELL_DEVELOPMENT_UP | 8.38e-05 | 167 | 112 | 6 | M1430 | |
| Coexpression | SANSOM_APC_TARGETS | 9.01e-05 | 245 | 112 | 7 | MM735 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.75e-04 | 191 | 112 | 6 | MM17059 | |
| Coexpression | TRAVAGLINI_LUNG_MYOFIBROBLAST_CELL | 1.75e-04 | 65 | 112 | 4 | M41673 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.01e-04 | 196 | 112 | 6 | M3008 | |
| Coexpression | GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_DN | 2.24e-04 | 200 | 112 | 6 | M5019 | |
| Coexpression | GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY15_EFFECTOR_CD8_TCELL_UP | 2.24e-04 | 200 | 112 | 6 | M9522 | |
| Coexpression | GSE18203_CTRL_VS_INTRATUMORAL_CPG_INJ_MC38_TUMOR_UP | 2.24e-04 | 200 | 112 | 6 | M7207 | |
| Coexpression | GSE2405_0H_VS_3H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP | 2.24e-04 | 200 | 112 | 6 | M6212 | |
| Coexpression | GSE36009_WT_VS_NLRP10_KO_DC_UP | 2.24e-04 | 200 | 112 | 6 | M8775 | |
| Coexpression | BROWN_MYELOID_CELL_DEVELOPMENT_UP | 2.30e-04 | 201 | 112 | 6 | MM1006 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | LAYN PRICKLE1 TNC LGR4 OLR1 USP20 GPR179 SLC6A6 SYNJ1 CRLF3 VCAN LTBP2 MMP2 OBI1 FAM131B | 2.63e-04 | 1242 | 112 | 15 | M1920 |
| Coexpression | GSE15624_CTRL_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_UP | 2.71e-04 | 133 | 112 | 5 | M7111 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500_k-means-cluster#3 | 2.52e-05 | 249 | 101 | 8 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#5 | 5.24e-05 | 276 | 101 | 8 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#1 | 6.99e-05 | 371 | 101 | 9 | Facebase_RNAseq_e9.5_Maxillary Arch_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#4 | 8.95e-05 | 298 | 101 | 8 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K4 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.64e-08 | 197 | 115 | 8 | 9ae6d987e65972e1fb21aa407788d5e3ff41ad64 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.67e-07 | 175 | 115 | 7 | 2a53d4f140d5ab096efe8118d8aa351db7838b49 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.67e-07 | 175 | 115 | 7 | fb91a45763e4c48d993094a13088ffc19f1e2574 | |
| ToppCell | facs-Brain_Myeloid-Cortex-24m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-07 | 179 | 115 | 7 | 0cef6d2eab2015cac0dd340532b24bfec9707330 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.43e-07 | 198 | 115 | 7 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | NS-moderate-d_07-13-Epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.02e-07 | 200 | 115 | 7 | 85940b4bf7971b872469dea8b8d7a45bdeb2a909 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Monophasic_Synovial_Sarcoma-5|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 4.34e-06 | 93 | 115 | 5 | 3e05ea0f8f4a7cdb78a596f47d563dc3c94d4d8e | |
| ToppCell | Basal_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 4.65e-06 | 166 | 115 | 6 | 23c04d1fba0c1733ccd0e4378fae2edde4fd0a7b | |
| ToppCell | facs-Aorta|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.50e-06 | 176 | 115 | 6 | 0b3491451be02c18a16cdb875645be47eb867a7f | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.50e-06 | 176 | 115 | 6 | e2b59a904c5c8f9c88e1e63788e9b6485f22edd0 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.50e-06 | 176 | 115 | 6 | f931192e3cc65414e2245354f443473696cc7ce8 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.16e-06 | 179 | 115 | 6 | 7078022e60faa86444f2a2c6eb9f767cc66b5cfa | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.16e-06 | 179 | 115 | 6 | d4a975d8ffa5e77fb5c0ec05bf9c8f843c77ce07 | |
| ToppCell | facs|World / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.88e-06 | 182 | 115 | 6 | 08f775135b451be709f5fc8e1cbcf63425794a2e | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 7.88e-06 | 182 | 115 | 6 | 812dac35b9aa05be48258082e007f6c00e7b4dd8 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.13e-06 | 183 | 115 | 6 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.65e-06 | 185 | 115 | 6 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 8.92e-06 | 186 | 115 | 6 | e044b3428b7eacfdc72d0f57cdabaa1de04c74cd | |
| ToppCell | E16.5-samps-Mesenchymal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 9.48e-06 | 188 | 115 | 6 | 3f0f662be684e3a4c6652e636cc135a39a1d2790 | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 1.07e-05 | 192 | 115 | 6 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | PND10-Mesenchymal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.20e-05 | 196 | 115 | 6 | ace167a40adb7022b365be3c2b1cbd4ba963739a | |
| ToppCell | PND03-Mesenchymal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.24e-05 | 197 | 115 | 6 | e3053ef8f604b6892c21c03e12612b49d3d30f23 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-epithelial_progenitor_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.24e-05 | 197 | 115 | 6 | c0250509836f1be04f5e54386191d7bb1e1da652 | |
| ToppCell | Epithelial_cells-Basal_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.27e-05 | 198 | 115 | 6 | 4235005c49fc2b29ad3a0ee6b608f0109d04f775 | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.27e-05 | 198 | 115 | 6 | 7063d74d79f53d5c59c853a2575f9d3ef12f19ea | |
| ToppCell | BL-critical-LOC-Epithelial-Secretory_LYPD2|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.27e-05 | 198 | 115 | 6 | 484d16aaa601a1e11b871b0475dd01a2de1a29ce | |
| ToppCell | E18.5-Mesenchymal|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.27e-05 | 198 | 115 | 6 | a16aa41eab2e297e56de43c22c355df0f79315da | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-05 | 198 | 115 | 6 | 19d8ff3a4f911b13ecc34844202925475ad4d2ab | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.27e-05 | 198 | 115 | 6 | fc00cb25cdc6c31b7f9d397bc9f9a8f4e9708003 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.31e-05 | 199 | 115 | 6 | d04062d86643e5712cc2f519f4f36e643d404a16 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.31e-05 | 199 | 115 | 6 | 8766796041965a1ba40ad7abdbc244bf1418c209 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.31e-05 | 199 | 115 | 6 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.31e-05 | 199 | 115 | 6 | a3f83fe5c3c557cd3ef8f5632f7fba5cf1859937 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-KRT5-/KRT17+|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.31e-05 | 199 | 115 | 6 | 3b1f56c8b40bb36922a31d2d440a8c468a8aa3f1 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.31e-05 | 199 | 115 | 6 | 644197ff7e3299587881dd678836262e670ed4a8 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.31e-05 | 199 | 115 | 6 | d39b40d84c72bdde756b805063317ecfad3784f8 | |
| ToppCell | Bronchial_Biopsy-Epithelial|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.31e-05 | 199 | 115 | 6 | ef5d8917c8d011184830a0b8197afc6266707b37 | |
| ToppCell | Severe_COVID-19-Epithelial-Basal/Club|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.31e-05 | 199 | 115 | 6 | 2a0aebcfadff4e2dfc8244ad8a87c338ecccacfd | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.31e-05 | 199 | 115 | 6 | fd364f43859b2e7a3e91ce6a1c430cc42ad26a49 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.35e-05 | 200 | 115 | 6 | f386a86b127433cbac306950443355bd723080ff | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.35e-05 | 200 | 115 | 6 | 41705bbba40eb5ddca0b223191aac1bce00163b8 | |
| ToppCell | Bronchial-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-05 | 200 | 115 | 6 | d3ee5f79513e2ac02ad3329b59e6290d457c44d2 | |
| ToppCell | Bronchial_Brush-Epithelial-Basal_2|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.35e-05 | 200 | 115 | 6 | 1fa29a9f42987549a75dffeb177099458f7cca88 | |
| ToppCell | Severe-Epithelial-Epithelial-|Severe / Condition, Lineage, Cell class and cell subclass | 1.35e-05 | 200 | 115 | 6 | 8669ce08f93eefb8ac970e30cdc4b1f908023c54 | |
| ToppCell | Bronchial_Brush-Epithelial-Basal_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.35e-05 | 200 | 115 | 6 | 7595eb2a8af3de879ecaa71f3d96f890e13b59ce | |
| ToppCell | Severe-Epithelial|Severe / Condition, Lineage, Cell class and cell subclass | 1.35e-05 | 200 | 115 | 6 | 6ead9db88568bb829d564a6d8e85f71fd765bac0 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Basal_3|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.35e-05 | 200 | 115 | 6 | 53e04399d0308b40ae99fbfaa4ff62bf061822d8 | |
| ToppCell | BAL-Severe-Epithelial|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.35e-05 | 200 | 115 | 6 | 0cc7ff7b6a4eb05d2370ec2f3b9dbfe8cb0699de | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.35e-05 | 200 | 115 | 6 | f5bc7d30aa03dd0f95eb64255bd1a2543be8d327 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.35e-05 | 200 | 115 | 6 | b75154417c215b8853186bff46d624ebd387ac4f | |
| ToppCell | BAL-Severe-Epithelial-Epithelial|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.35e-05 | 200 | 115 | 6 | b9cede2e0939c6b60ce1aa16d7efaaae79354580 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_3|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.35e-05 | 200 | 115 | 6 | cc8df398532c9324fd3e171000b1ea5c208cd691 | |
| ToppCell | BAL-Severe-Epithelial|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.35e-05 | 200 | 115 | 6 | b762bf6f432eac05a476f6e2ab4da27dd13a2317 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.35e-05 | 200 | 115 | 6 | 4c63204e0d868dd4c11c1604a238624a3ad54485 | |
| ToppCell | Severe_COVID-19-Epithelial|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.35e-05 | 200 | 115 | 6 | 49910efb6d888c208cd50530b03af19f87070630 | |
| ToppCell | Severe-Epithelial-Epithelial|Severe / Condition, Lineage, Cell class and cell subclass | 1.35e-05 | 200 | 115 | 6 | 3bd1ce2793651c9badd69f011d2531183594e5f4 | |
| ToppCell | Basal_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 6.72e-05 | 164 | 115 | 5 | 85487a303194f5244956ec1ca2d1758d38117f41 | |
| ToppCell | facs-Spleen-nan-18m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 166 | 115 | 5 | 8d535fab019356894b4dad3fbdbc4d2ad3e16082 | |
| ToppCell | facs-Spleen-nan-18m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 166 | 115 | 5 | f56b1c0d6cb5353a16a2598bda905287f16d2c39 | |
| ToppCell | facs-Spleen-nan-18m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 166 | 115 | 5 | a5074c96c6561273029aceb93402a7e038140f50 | |
| ToppCell | Control-Epithelial_airway-Club_cells-Airway|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.53e-05 | 168 | 115 | 5 | ce87981f4da2779de952c2e5d2bbcdabb265e705 | |
| ToppCell | Control-Epithelial_airway-Club_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.53e-05 | 168 | 115 | 5 | e85bc5398eb36b2b0773a8a7082e3ba740452165 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9|TCGA-Bladder / Sample_Type by Project: Shred V9 | 8.19e-05 | 171 | 115 | 5 | adbcfa4bf6bc1c604535a24435924cdb091e2dd7 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_2|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.19e-05 | 171 | 115 | 5 | 26b34dc069cc15b75a0c13cb8c5d81e074788160 | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 8.42e-05 | 172 | 115 | 5 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.42e-05 | 172 | 115 | 5 | b66dbfff5e4f53ca8ece91ff9c5dc66a71f07c63 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.65e-05 | 173 | 115 | 5 | f9d6e892d66f9b94e4d5beb9f5dec9b606bc868a | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.65e-05 | 173 | 115 | 5 | cbd65dd5b01cc959e3ccbc89330ddd0122296ea3 | |
| ToppCell | droplet-Thymus-nan-3m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.65e-05 | 173 | 115 | 5 | 63f03abca84ae021ff34ff34537838aa8a1ccd11 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.65e-05 | 173 | 115 | 5 | 789ab8b2709f4b8728e3733bc72744e9d92ea5ea | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.89e-05 | 174 | 115 | 5 | 197686570cec6d96a92e77e6409325d3bfe6f991 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.89e-05 | 174 | 115 | 5 | 2eee7b5471672b439f95eba11494c2adf8cb7006 | |
| ToppCell | Hippocampus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 9.12e-05 | 91 | 115 | 4 | f59908093416ca7b3ca27019d71c79acbdea18cb | |
| ToppCell | Hippocampus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 9.12e-05 | 91 | 115 | 4 | 104d2ab9fe5cc404388c32fafb34e421c2e138be | |
| ToppCell | Hippocampus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 9.12e-05 | 91 | 115 | 4 | 78e2e65beb15bf1e251974c72fbcfab817492772 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.13e-05 | 175 | 115 | 5 | 1d8aab491dcc27ea5dbfb6462d18ee280b21a05e | |
| ToppCell | AT1-AT2_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 9.13e-05 | 175 | 115 | 5 | bdd85ba280648a0283c1984662a34c7b840f64dd | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-conventional_dendritic_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.13e-05 | 175 | 115 | 5 | c58a1f02d1e559d3638fe1500e960e82a8a7187b | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.13e-05 | 175 | 115 | 5 | 427a7ee92fe16a90625946492062d37aa0f7235b | |
| ToppCell | facs-Pancreas-Endocrine-18m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.38e-05 | 176 | 115 | 5 | 9ddf87e586d2378984cd007c60f7dc254845f8f3 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.38e-05 | 176 | 115 | 5 | e987e741fcf1bed8598a5060700efd3018f8123b | |
| ToppCell | AT1-AT2_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 9.38e-05 | 176 | 115 | 5 | f86832cfeff5b3cfffe4455c1b96a1420d48ba1e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122|Adult / Lineage, Cell type, age group and donor | 9.38e-05 | 176 | 115 | 5 | 3fee8a367bb9755aca1b7fcc968b08e51b6e9436 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.38e-05 | 176 | 115 | 5 | 92ebcea9b2b22601234b76d7a98f0410b905a87b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.63e-05 | 177 | 115 | 5 | cbad1a23851151dbef01ea2af960e6f0944f838b | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.89e-05 | 178 | 115 | 5 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.02e-04 | 179 | 115 | 5 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | facs-Brain_Myeloid-Cortex-24m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 179 | 115 | 5 | bc93883c2094f2e5bfed79facd4994a23968d875 | |
| ToppCell | facs-Brain_Myeloid-Cortex-24m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 179 | 115 | 5 | bb2410b3934fcc53396b96b48e0d9843df159b89 | |
| ToppCell | Epithelial-basal_cell|World / Lineage, Cell type, age group and donor | 1.02e-04 | 179 | 115 | 5 | d9be6647ec7b22747dc00dce4ea307b6af412dfa | |
| ToppCell | facs-Brain_Myeloid-Cortex-24m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 179 | 115 | 5 | 065241799cea30da62cb3b6f2f1970bd1b0f4e2b | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 180 | 115 | 5 | 0153667e44fdbc3c0d444dcb023069925a2b69a2 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 180 | 115 | 5 | 40a28b410f46215d6d7cf8a02a18078eb046b5b0 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 180 | 115 | 5 | f6a05b3751b01e74b2de8440801b0eb2e723c199 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 180 | 115 | 5 | dfc75ae4395ff46fbec2c54915d98ead5a1ba1a1 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-mesothelial_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-04 | 181 | 115 | 5 | 65eaa9bc1022bcf0c5f0f92c07a2cbbf11f9b59c | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 181 | 115 | 5 | 269b39ac65790061d54eab47a8eeb024403f0348 | |
| ToppCell | RA-07._Pericyte|RA / Chamber and Cluster_Paper | 1.07e-04 | 181 | 115 | 5 | 8dfb42d096db6c2df9b41303a7199d134d4bff07 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 181 | 115 | 5 | cd4f744b6b64ba6c22ec07afd1d3058a2546909d | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 181 | 115 | 5 | c8395ae872aa80b3ae1ab7c53e57b3ca15aeb0e2 | |
| Disease | Nonsyndromic Deafness | 3.65e-07 | 81 | 101 | 6 | C3711374 | |
| Disease | syntaxin-1a measurement | 1.15e-04 | 5 | 101 | 2 | EFO_0020759 | |
| Disease | interleukin-36 alpha measurement | 4.11e-04 | 9 | 101 | 2 | EFO_0021851 | |
| Disease | Marfan Syndrome | 6.25e-04 | 11 | 101 | 2 | C0024796 | |
| Disease | intracranial aneurysm (is_implicated_in) | 7.49e-04 | 12 | 101 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | cutaneous melanoma | 8.08e-04 | 121 | 101 | 4 | EFO_0000389 | |
| Disease | cholangiocarcinoma (biomarker_via_orthology) | 8.83e-04 | 13 | 101 | 2 | DOID:4947 (biomarker_via_orthology) | |
| Disease | Metabolic Bone Disorder | 1.03e-03 | 14 | 101 | 2 | C0005944 | |
| Disease | high grade glioma (biomarker_via_orthology) | 1.18e-03 | 15 | 101 | 2 | DOID:3070 (biomarker_via_orthology) | |
| Disease | Osteopenia | 1.18e-03 | 15 | 101 | 2 | C0029453 | |
| Disease | myopia (is_implicated_in) | 1.35e-03 | 16 | 101 | 2 | DOID:11830 (is_implicated_in) | |
| Disease | PR interval | 1.59e-03 | 495 | 101 | 7 | EFO_0004462 | |
| Disease | autoimmune thyroid disease, Hashimoto's thyroiditis, Graves disease | 1.71e-03 | 18 | 101 | 2 | EFO_0003779, EFO_0004237, EFO_0006812 | |
| Disease | serum alanine aminotransferase measurement, response to combination chemotherapy | 1.88e-03 | 71 | 101 | 3 | EFO_0004735, EFO_0007965 | |
| Disease | sensorineural hearing loss (implicated_via_orthology) | 1.91e-03 | 19 | 101 | 2 | DOID:10003 (implicated_via_orthology) | |
| Disease | Pseudopelade | 1.91e-03 | 19 | 101 | 2 | C0086873 | |
| Disease | myocardial infarction (biomarker_via_orthology) | 2.26e-03 | 160 | 101 | 4 | DOID:5844 (biomarker_via_orthology) | |
| Disease | Endometrioma | 2.31e-03 | 161 | 101 | 4 | C0269102 | |
| Disease | Endometriosis | 2.31e-03 | 161 | 101 | 4 | C0014175 | |
| Disease | periodontitis (biomarker_via_orthology) | 2.33e-03 | 21 | 101 | 2 | DOID:824 (biomarker_via_orthology) | |
| Disease | response to selective serotonin reuptake inhibitor | 2.83e-03 | 82 | 101 | 3 | EFO_0005658 | |
| Disease | vital capacity | 3.38e-03 | 1236 | 101 | 11 | EFO_0004312 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SFGANIWCLDNDYHT | 86 | Q495M9 | |
| AACSEYFWQALVGQT | 56 | Q9BYV9 | |
| LCSADSFCVNDYTWG | 351 | Q63HQ2 | |
| FDQCDYGWLSDASVR | 291 | P13611 | |
| SNIWVAGDAACFYDI | 431 | O95831 | |
| SASGWCFFTLENLIY | 3266 | Q8WXG9 | |
| NFSSSWSDGLAFCAL | 986 | Q5M775 | |
| FSSSWNDGLAFCALL | 1036 | Q69YQ0 | |
| LWCANILGYAVSTFA | 181 | Q9UBM7 | |
| CAWVAVYCSFISFAN | 56 | Q9Y284 | |
| GRSDGFLWCSTTYNF | 251 | P08253 | |
| ATTANYDDDRKWGFC | 376 | P08253 | |
| AFSFSAWFCLDQDQL | 591 | Q6ZS30 | |
| SSALAANGWVFLLAY | 246 | Q8NFJ5 | |
| ASVYWLAGAQACFTT | 416 | Q14728 | |
| AEAAVTWVAYSAFAA | 271 | Q9BZJ7 | |
| GYSLSDWLCLAFVES | 41 | O75951 | |
| ASNFSLWSAAYCSSA | 11 | Q14774 | |
| LCAFLSLSWYAALSG | 16 | Q9UQ53 | |
| WGSFLCYATRAVLSA | 556 | Q6PRD1 | |
| FNARFSLDDCSWYGE | 76 | Q6A163 | |
| CQDLYAWTDGSISQF | 121 | Q6UX15 | |
| AWYVAACRANVKSGA | 846 | O75335 | |
| CYGGTASLFNAANWM | 166 | P54868 | |
| RWGNYSTGDCFILAS | 1576 | Q96RV3 | |
| AYGLFQECSSRVASW | 566 | Q86V87 | |
| DKIGFYLQSDNSACW | 131 | O95373 | |
| CADIRLNSWYGFALA | 191 | Q8NH59 | |
| SGASYLAEQCWNGGF | 156 | O15018 | |
| DWLCAQYLAFATTDS | 1721 | Q9H792 | |
| DWLLDQSCGSLYFGC | 416 | Q8IUI8 | |
| WCQGLAFFSPAYAAS | 281 | Q8N2G8 | |
| FWDCCSTSYAQNLDF | 466 | Q5W0B1 | |
| SYGADGTLCWSRFAQ | 421 | P0DUQ1 | |
| FIWSAASAAYQIEGA | 1381 | P09848 | |
| CAFWGCDSYANLNTE | 471 | Q9BXB1 | |
| GSAWAAAAAQCRYGD | 396 | P10275 | |
| SSGWCIFIYNLGQDA | 241 | Q15717 | |
| HGENCYLFSSGSFNW | 151 | P78380 | |
| TDSGCYSAFVVWARS | 481 | Q8IYI6 | |
| ALGCSWLGYSSAFAS | 141 | Q96P69 | |
| WLAAIYIGDSFCAGS | 421 | Q04756 | |
| YCLGSSDAWEASDQS | 196 | Q86XD5 | |
| YALAWATNSIVAAGC | 201 | Q9UG01 | |
| SCAQLAAASWFSGFS | 141 | Q9H209 | |
| EGWSNAFYDSCVNSV | 641 | Q9H0J9 | |
| FLGLYGEDDDSWCSS | 751 | Q96MT3 | |
| FENRYSDAGSSWAGA | 201 | Q2TBC4 | |
| ESYDAQGALCWGRFS | 416 | O95522 | |
| AAFLCSDYASWINGA | 281 | Q16698 | |
| AGHYASATLWVAFCF | 176 | Q1HG44 | |
| YNDALAWSFGKVCSL | 301 | Q9UKF2 | |
| CALSFSQELDYWGID | 111 | Q14721 | |
| ALGWCFGEQAYLRSS | 1331 | O43497 | |
| FGQALFTGWAAASLC | 161 | O95832 | |
| ANCFWRIYAEAKTSG | 236 | Q8TDV2 | |
| YDALLAAGNSWTELC | 281 | Q8NDY3 | |
| ENLWFSCATDSLGVY | 46 | P56746 | |
| GSFACSACENGYWVN | 1071 | Q14767 | |
| CWAFSSLAEAAYEAA | 471 | Q14974 | |
| GQCVLAGAFASFYWA | 461 | Q53GD3 | |
| QAFSFCTAGRWAAGE | 266 | A4GXA9 | |
| ESYDTQGALCWGRFA | 416 | Q5VWM4 | |
| SLADWVCLAYFTSGF | 111 | Q8IXA5 | |
| AAGSLSVFASYAFWN | 171 | Q14CX5 | |
| NFTYSCQNAAAWLDE | 1646 | P25940 | |
| DSLYCAAGAWALALA | 86 | Q93100 | |
| LAAHCYACDSAFWLA | 1121 | Q13615 | |
| CFQLAAASWISGFSN | 141 | Q9GZK3 | |
| ASYTWSDAAAAFAGL | 396 | Q96RQ9 | |
| QSAFTLAWDGASAVY | 256 | Q6ZRI0 | |
| WLEGVFYAALNICTA | 236 | Q6NXP6 | |
| CAFGSAAIWQYESLK | 111 | Q9H300 | |
| WIDAGTQIFFSYAIC | 291 | P31641 | |
| YAASGVCLLWVAFFE | 461 | P31641 | |
| FFCQYSADLWNIGIS | 246 | Q6ZUK4 | |
| RCTYLLAGAADSTWA | 216 | A2VEC9 | |
| YACSSAFWAAALLTL | 296 | Q8IW70 | |
| GNFYFAWSASGISLD | 126 | O43426 | |
| FYQGLWDCTGAFSDE | 301 | O75563 | |
| WLSAIGLECYQDNFS | 956 | O15197 | |
| SYGADGTLCWNRFAQ | 421 | A3QJZ7 | |
| WNKDVCAASGDRFAY | 41 | Q8IZU2 | |
| DTTWNCGYLLASSFV | 56 | O15260 | |
| CALAAEGIWTYTFVF | 396 | Q7RTR0 | |
| GDALLASAQSQVWYC | 401 | Q96EP0 | |
| WSGVLQGAATCFYAF | 251 | Q8TBB6 | |
| ESYDTQGALCWGRFA | 416 | Q5VXH5 | |
| SYGADGTLCWSRFAQ | 421 | O60810 | |
| SAYSLGGFAAEWLSQ | 3271 | Q63HN8 | |
| AYTFQASGQALCRGW | 661 | O94827 | |
| NVNKYWLSSACGSDF | 406 | Q8TDR2 | |
| WDSTGDYCLSCLFAQ | 166 | Q2NL82 | |
| FANYSTCDRSNLADW | 476 | Q6SZW1 | |
| GECWTFAQLDAYSNA | 101 | Q6PCB7 | |
| SLDSRLFYSFWGSCQ | 331 | Q9HCF6 | |
| LFYSFWGSCQLDSVG | 336 | Q9HCF6 | |
| SYGADGTLCWSRFAQ | 421 | P0DUQ2 | |
| ACYQVWAVARDGSAF | 996 | Q7Z6L1 | |
| DGLAESSYGRWLCNF | 1056 | O94964 | |
| SAITNCALSYKGAFW | 2131 | P24821 | |
| CGYVAFSVGNFFASW | 76 | Q86WB7 | |
| LDSATGNWFSACFDN | 116 | Q9NRS4 | |
| GNWFSACFDNFTEAL | 121 | Q9NRS4 | |
| SYGADGTLCWSRFAQ | 421 | O60813 | |
| WGDAASQIFYSLGCA | 361 | P48067 | |
| LFDALTWFGYFNSTC | 296 | Q9P1P5 | |
| AESAWCYLYGTGSVA | 3816 | Q15149 | |
| LTSRDAGFYWCLTNG | 431 | P01833 | |
| CLDSLGQWNYTFAST | 121 | P30408 | |
| GACGDSYAAQGWLAF | 501 | Q9Y2K6 | |
| AWGRADCGFTSESYQ | 261 | P0DTU4 | |
| ESGQLSAFYLFACVW | 121 | Q15629 | |
| ACGSSEGTIYLFNWN | 226 | Q9H6Y2 | |
| QWSGCSDNIAYGVAF | 151 | P56705 | |
| GCRDWEAFSTTAGAY | 636 | Q8WU66 | |
| SYSLQGSIFRNDWEC | 111 | Q9HCL3 | |
| NFSLDWDLGNYSVLC | 641 | Q86VR7 | |
| TILYAGINFSCWSAL | 316 | Q6PP77 | |
| ASADWCEIFGYFSSE | 86 | B1ANS9 |